Aboutara N, Jungen H, Szewczyk A, Müller A, Iwersen‐Bergmann S. PEth 16: 0/18: 1 and 16: 0/18: 2 after consumption of low doses of alcohol—A contribution to cutoff discussion. Drug Testing and Analysis. 2023 Jan;15(1):104-14.

Dumitrascu C, Gys C, Wille SM, del Mar Ramiréz‐Fernandéz M, D'Hondt D, Van Goethem A, Van Rafelghem B, Baetens E, Jacobs W, Neels H, Covaci A. The complementarity of phosphatidylethanol in whole blood and ethyl glucuronide in hair as biomarkers for the monitoring of alcohol use. Drug Testing and Analysis. 2023 Jul 28.

Herzog J, Skopp G, Musshoff F. Monitoring of phosphatidylethanol in dried blood spots and of ethyl glucuronide in hair over 6 months of alcohol consumption. Drug Testing and Analysis. 2023 Jul 24.

Novak L, Soravia LM, Bünter A, Stöth F, Wopfner A, Weinmann W, Pfeifer P. Alcohol biomarker phosphatidylethanol as a predictor of the severity of alcohol withdrawal syndrome. Alcohol and alcoholism. 2023 Mar;58(2):198-202.

Perilli M, Toselli F, Franceschetto L, Cinquetti A, Ceretta A, Cecchetto G, Viel G. Phosphatidylethanol (PEth) in Blood as a Marker of Unhealthy Alcohol Use: A Systematic Review with Novel Molecular Insights. International Journal of Molecular Sciences. 2023 Jul 29;24(15):12175.

Salah LM, Bushman LR, Brooks KM, Anderson PL, Kiser JJ. Development and validation of an LC-MS/MS method to quantify the alcohol biomarker phosphatidylethanol 16: 0/18: 1 in dried blood spots for clinical research purposes. Journal of Chromatography B. 2023 May 1;1223:123725.

Skråstad RB, Aamo TO, Andreassen TN, Havnen H, Hveem K, Krokstad S, Salvesen Ø, Spigset O. Quantifying alcohol consumption in the general population by analysing Phosphatidylethanol concentrations in whole blood: results from 24,574 subjects included in the HUNT4 study. Alcohol and Alcoholism. 2023 May;58(3):258-65.

Stöth F, Weinmann W, Soravia LM, Pfeifer P. Evaluation of phosphatidylethanol elimination in alcohol use disorder patients undergoing withdrawal treatment. Alcohol and alcoholism. 2023 May;58(3):266-73.

Van Uytfanghe K, Stove CP. Increasing Confidence in a Phosphatidylethanol 16: 0/18: 1 Cutoff at 20 ng/mL to Support Abstinence or Minor Intake of Alcohol. Clinical Chemistry. 2023 Jul 10:hvad096.

Alcover KC, Emenyonu NI, Fatch R, Kekibiina A, Marson K, Chamie G, Muyindike WR, Beesiga B, Kamya MR, Lodi S, Kane JC. Concordance between point-of-care urine ethyl glucuronide alcohol tests and self-reported alcohol use in persons with HIV in Uganda. AIDS and Behavior. 2022 Aug;26(8):2539-47.

Fatch R, Luginbühl M, Cheng DM, Gaugler S, Emenyonu NI, Ngabirano C, Adong J, Muyindike WR, Samet JH, Bryant K, Hahn JA. Comparison of automated determination of phosphatidylethanol (PEth) in dried blood spots (DBS) with previous manual processing and testing. Alcohol. 2022 Feb 1;98:51-4.

Luginbuhl M, Wurst FM, Stoth F, Weinmann W, Stove C, Van Uytfanghe K. Consensus for the use of the alcohol biomarker phosphatidylethanol (PEth) for the assessment of abstinence and alcohol consumption in clinical and forensic practice (2022 consensus of Basel). Drug testing and analysis. 2022;14(10):1800-2.

Hahn JA, Murnane PM, Vittinghoff E, Muyindike WR, Emenyonu NI, Fatch R, Chamie G, Haberer JE, Francis JM, Kapiga S, Jacobson K. Factors associated with phosphatidylethanol (PEth) sensitivity for detecting unhealthy alcohol use: An individual patient data meta‐analysis. Alcoholism: Clinical and Experimental Research. 2021 Jun;45(6):1166-87.

Wang Y, Fridberg DJ, Leeman RF, Cook RL, Porges EC. Wrist-worn alcohol biosensors: Strengths, limitations, and future directions. Alcohol. 2019 Dec 1;81:83-92.

Ulwelling W, Smith K. The PEth blood test in the security environment: what it is; why it is important; and interpretative guidelines. Journal of Forensic Sciences. 2018 Nov;63(6):1634-40.

Hahn JA, Anton RF, Javors MA. The formation, elimination, interpretation and future research needs of phosphatidylethanol (PEth) for research studies and clinical practice. Alcoholism, clinical and experimental research. 2016 Nov;40(11):2292.